Authors:
Bolwell, B
Andresen, S
Pohlman, B
Sobecks, R
Goormastic, M
Rybicki, L
Bell, K
Kalaycio, M
Citation: B. Bolwell et al., Prognostic importance of the axillary lymph node ratio in autologous transplantation for high-risk stage II/III breast cancer, BONE MAR TR, 27(8), 2001, pp. 843-846
Authors:
van Stolk, R
Stoner, G
Hayton, WL
Chan, K
DeYoung, B
Kresty, L
Kemmenoe, BH
Elson, P
Rybicki, L
Church, J
Provencher, K
McLain, D
Hawk, E
Fryer, B
Kelloff, G
Ganapathi, R
Budd, GT
Citation: R. Van Stolk et al., Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis, CLIN CANC R, 6(1), 2000, pp. 78-89
Citation: D. Walsh et al., The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients, SUPP CARE C, 8(3), 2000, pp. 175-179
Authors:
Pelley, R
Ganapathi, R
Wood, L
Rybicki, L
McLain, D
Budd, GT
Peereboom, D
Olencki, T
Bukowski, RM
Citation: R. Pelley et al., A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer, CANC CHEMOT, 46(3), 2000, pp. 251-254
Authors:
Kotagal, P
Bleasel, A
Geller, E
Kankirawatana, P
Moorjani, BI
Rybicki, L
Citation: P. Kotagal et al., Lateralizing value of asymmetric tonic limb posturing observed in secondarily generalized tonic-clonic seizures, EPILEPSIA, 41(4), 2000, pp. 457-462
Authors:
Uzzo, RG
Clark, PE
Rayman, P
Bloom, T
Rybicki, L
Novick, AC
Bukowski, RM
Finke, JH
Citation: Rg. Uzzo et al., Alterations in NF kappa B activation in T lymphocytes of patients with renal cell carcinoma, J NAT CANC, 91(8), 1999, pp. 718-721
Authors:
Ciezki, JP
Hafeli, UO
Song, P
Urankar-Nagy, N
Ratliff, NB
Rybicki, L
Brill, K
Meier, D
Citation: Jp. Ciezki et al., Parenchymal cell proliferation in coronary arteries after percutaneous transluminal coronary angioplasty: A human tissue bank study, INT J RAD O, 45(4), 1999, pp. 963-968
Authors:
Kolenko, V
Rayman, P
Roy, B
Cathcart, MK
O'Shea, J
Tubbs, R
Rybicki, L
Bukowski, R
Finke, J
Citation: V. Kolenko et al., Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E-2 and other cyclic adenosine monophosphate-elevating agents: Impact on interleukin-2 receptor signaling pathway, BLOOD, 93(7), 1999, pp. 2308-2318
Authors:
Shetty, K
Rybicki, L
Brzezinski, A
Carey, WD
Lashner, BA
Citation: K. Shetty et al., The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis, AM J GASTRO, 94(6), 1999, pp. 1643-1649